Investment Rating - The investment rating for the company is "Accumulate" (maintained) [2] Core Views - The company has shown a rapid recovery in Q2 performance, with a focus on the "Culture + Technology" strategy, leading to significant revenue and profit growth [7][8] - The company achieved a revenue of 1.004 billion yuan in the first half of 2025, representing a year-on-year increase of 52.16%, and a net profit of 75 million yuan, up 56.81% year-on-year [7][8] - The company is expected to achieve revenues of 26.34 billion yuan, 32.19 billion yuan, and 36.60 billion yuan for the years 2025, 2026, and 2027 respectively, with net profits of 1.35 billion yuan, 1.70 billion yuan, and 1.89 billion yuan for the same years [7][8] Financial Performance Summary - Revenue for 2023 is projected at 1,938 million yuan, with a decline of 31.8% year-on-year, followed by a slight decrease of 4.9% in 2024, and a recovery of 42.9% in 2025 [6][9] - Net profit for 2023 is expected to be 101 million yuan, with a significant drop of 64.8% year-on-year, followed by a further decline of 36.0% in 2024, and a rebound of 108.2% in 2025 [6][9] - The company's earnings per share (EPS) is projected to be 0.25 yuan in 2023, decreasing to 0.16 yuan in 2024, and then increasing to 0.31 yuan in 2025 [6][9] - The price-to-earnings (PE) ratio is expected to be 54.5 in 2023, 70.6 in 2024, and decreasing to 42.1 in 2025 [6][9] Business Strategy and Developments - The company is focusing on the full industry chain layout of cultural and sports tourism, with an emphasis on "Culture + Technology" [7][8] - The company has secured exclusive rights for the opening and closing ceremonies of the 2026 Aichi-Nagoya Asian Games and has been included in the national cultural export key project list [7][8] - The company has launched its own night tour IP "Tonight" series, introducing an innovative "multi-perspective immersive" viewing mode [7][8] - The company has formed a joint venture with Zhiyuan Robotics to explore the high-potential intersection of humanoid robots and cultural tourism [7][8]

第二章 募集资金的存放 泰瑞机器股份有限公司 募集资金管理制度 （2025 年 8 月修订） 第一章 总则 第一条 为规范泰瑞机器股份有限公司（以下简称"公司"）募集资金的存放、 管理与使用，确保资金使用的安全，提高其使用效率和效益，保护投资者权益。 根据《中华人民共和国公司法》、《中华人民共和国证券法》、《上海证券交 易所上市公司自律监管指引第 1 号——规范运作》、《上市公司募集资金监管 规则》等法律法规、规范性文件和《泰瑞机器股份有限公司章程》（以下简称 "《公司章程》"）的规定，结合公司实际情况，特制定本制度。 第二条 本制度适用于公司通过发行股票或者其他具有股权性质的证券，向 投资者募集并用于特定用途的资金监管，但不包括公司为实施股权激励计划募 集的资金监管。 第三条 募集资金投资项目（以下简称"募投项目"）通过公司的子公司或公 司控制的其他企业实施的，适用本制度。募集资金应按募集说明书或其他募集 文件承诺的使用计划及进度使用，并且应专户存放、专款专用。 公司应当审慎使用募集资金，保证募集资金的使用与募集说明书的承诺相 一致，不得随意改变募集资金的投向。非经公司股东会依法作出决议，不得改 变公司募集 ...

泰瑞机器股份有限公司 独立董事工作制度 （2025 年 8 月修订） 第一章 总则 第一条 按照建立现代企业制度的要求，进一步完善泰瑞机器股份有限公司 （以下简称"公司"）治理结构，促进公司的规范运作，维护公司整体利益，提高 公司决策的科学性，根据《中华人民共和国公司法》（以下简称"《公司法》"）、 《中华人民共和国证券法》、《上市公司独立董事管理办法》、《上海证券交易 所上市公司自律监管指引第 1 号—规范运作》和《泰瑞机器股份有限公司章程》 （以下简称"《公司章程》"）的有关规定，制定本制度。 第二条 独立董事是指不在公司担任除董事外的其他职务，并与公司及其主 要股东、实际控制人不存在直接或者间接利害关系，或者其他可能影响其进行独 立客观判断关系的董事。 独立董事应当独立履行职责，不受公司及其主要股东、实际控制人等单位或 者个人的影响。 第三条 独立董事对公司及全体股东负有忠实与勤勉义务。独立董事应当按 照相关法律、行政法规、中国证券监督管理委员会（以下简称"中国证监会"） 规定、上海证券交易所（以下简称"上交所"）业务规则和公司章程的规定，认 真履行职责，在董事会中发挥参与决策、监督制衡、专业咨询作用， ...

艾迪精密公告，2025年上半年营业收入15.69亿元，同比增长13.15%。净利润2.07亿元，同比增长 5.34%。 ...

Investment Rating - The investment rating for the company is "Accumulate" (maintained) [1] Core Views - The company has shown significant year-on-year growth in performance, driven by the fulfillment of full-route orders and the domestic substitution in semiconductor wet processes [1] - The company has achieved full coverage of TOPCon, HJT, perovskite, and perovskite tandem routes in photovoltaic equipment [1] - The company is expanding into the semiconductor and lithium battery sectors, gradually improving its specialized equipment platform layout [1] Financial Performance Summary - For the first half of 2025, the company reported total revenue of 8.372 billion yuan, a year-on-year increase of 26.41%, with a net profit attributable to shareholders of 1.830 billion yuan, up 49.26% year-on-year [7] - The gross margin for the first half of 2025 was 29.65%, a slight decrease of 1.97 percentage points year-on-year, while the net profit margin improved to 21.87%, an increase of 3.35 percentage points year-on-year [7] - The company’s cash flow from operating activities was -0.776 billion yuan, a significant decrease of 496.77% year-on-year, primarily due to reduced payments received and funds frozen due to litigation [7] Revenue and Profit Forecast - The forecast for net profit attributable to shareholders for 2025-2027 has been adjusted to 2.54 billion (previously 2.14 billion), 1.53 billion (previously 1.09 billion), and 1.52 billion (previously 0.95 billion) yuan respectively [1] - The current stock price corresponds to dynamic P/E ratios of 14, 22, and 23 times for 2025, 2026, and 2027 respectively [1] Market Data - The closing price of the stock is 98.77 yuan, with a market capitalization of approximately 34.34 billion yuan [5] - The company has a price-to-book ratio of 2.75 and a total circulating A-share market value of approximately 28.36 billion yuan [5]

Core Points - The company held its 17th meeting of the 8th Supervisory Board on August 28, 2025, where all three supervisors attended, confirming the meeting's legality and effectiveness [1] - The Supervisory Board approved the 2025 Half-Year Report, affirming that it accurately reflects the company's actual situation without any false records or significant omissions [1] - The Supervisory Board also approved the proposal for impairment provisions, stating that it complies with accounting standards and accurately reflects the company's asset status [1] - The meeting approved the proposal for new daily related transactions for 2025, ensuring that the decision-making process adheres to legal regulations and does not harm the interests of non-related shareholders [2]

（二）股东会的召集人：公司董事会 （三）会议召开的合法、合规性：公司于 2025 年 8 月 28 日召开第八届董事 会第二十四次会议，审议通过了《关于召开 2025 年第二次临时股东会的议案》， 会议的召集、召开符合相关法律、行政法规、部门规章、规范性文件、深圳证券 交易所业务规则及《公司章程》的规定。 （四）会议召开的日期、时间： 网络投票系统包括深圳证券交易所交易系统和互联网投票系统 证券代码：002097 证券简称：山河智能 公告编号：2025-050 山河智能装备股份有限公司 关于召开 2025 年第二次临时股东会的通知 本公司及董事会全体成员保证信息披露内容的真实、准确和完整，没有虚假记载、误 导性陈述或重大遗漏。 山河智能装备股份有限公司（以下简称"公司"或"本公司"）董事会决定 召集 2025 年第二次临时股东会。根据《公司章程》，本次股东会采用现场投票、 网络投票相结合的方式，有关会议召开具体事项如下： 一、召开会议的基本情况 （一）股东会届次：2025 年第二次临时股东会 （八）现场会议召开地点：湖南长沙市星沙产业基地长龙街道凉塘东路 1335 号 山河智能总部大楼 405 会议室 二、会 ...

Market Performance - The specialized equipment sector increased by 0.12% on August 29, with Zhuolang Intelligent leading the gains [1] - The Shanghai Composite Index closed at 3857.93, up 0.37%, while the Shenzhen Component Index closed at 12696.15, up 0.99% [1] Top Gainers - Zhuolang Intelligent (600545) closed at 2.96, up 10.04% with a trading volume of 1.1171 million shares and a transaction value of 320 million yuan [1] - Zhongchuang Zhiling (601717) closed at 20.45, up 10.01% with a trading volume of 557,300 shares and a transaction value of 1.131 billion yuan [1] - Jincai Hulian (002530) closed at 11.70, up 9.96% with a trading volume of 1.2198 million shares and a transaction value of 1.385 billion yuan [1] Top Losers - Lanying Equipment (300293) closed at 25.13, down 9.44% with a trading volume of 517,500 shares [2] - Lian Ce Technology (688113) closed at 40.51, down 8.56% with a trading volume of 39,000 shares [2] - Greebo (301260) closed at 21.91, down 8.44% with a trading volume of 212,900 shares [2] Capital Flow - The specialized equipment sector experienced a net outflow of 1.934 billion yuan from institutional investors, while retail investors saw a net inflow of 1.146 billion yuan [2][3] - The sector's overall capital flow indicates a mixed sentiment, with retail investors showing interest despite institutional outflows [2][3] Individual Stock Capital Flow - Jincai Hulian (002530) had a net inflow of 411 million yuan from institutional investors, but a net outflow of 1.93 billion yuan from speculative funds [3] - Zhuolang Intelligent (600545) saw a net inflow of 84.64 million yuan from institutional investors, with significant outflows from both speculative and retail investors [3]

Investment Rating - The investment rating for the company is "Buy" and is maintained [9] Core Views - The company reported a revenue of 7.327 billion yuan for the first half of 2025, representing a year-on-year increase of 8.92%, and a net profit attributable to shareholders of 479 million yuan, up 9.61% year-on-year [2][6] - The gas sales business is recovering, with a 14.12% year-on-year increase in gas sales revenue, while the petrochemical product revenue grew by 50.28% [12] - The company is actively expanding into overseas markets, achieving a 78.89% year-on-year growth in overseas sales [12] - The gross profit margin for Q2 2025 was 20.05%, a decrease of 1.44 percentage points year-on-year, but is expected to recover in the second half of 2025 [12] - Operating cash flow improved significantly, reaching 1.215 billion yuan in H1 2025, an increase of 97.84% year-on-year [12] Summary by Sections Financial Performance - In H1 2025, the company achieved a total revenue of 73.27 billion yuan, with Q2 revenue at 37.63 billion yuan, both showing positive year-on-year growth [2][6] - The net profit for H1 2025 was 4.79 billion yuan, with Q2 net profit at 2.53 billion yuan, indicating consistent profitability [2][6] Business Segments - The gas sales business showed a year-on-year increase of 14.12%, while the engineering contracting business saw a decline of 44.05% [12] - The company maintained a leading position in the domestic market for petrochemical equipment, with a record contract amount of 8.41 billion yuan in H1 2025 [12] Market Expansion - The company has made significant strides in overseas markets, with a notable increase in sales and the establishment of subsidiaries in Southeast Asia [12] - The gross margin for overseas sales improved by 5.34 percentage points, benefiting from competitive pricing and tax rebate policies [12] Future Outlook - The company anticipates a steady increase in gas sales volume and the successful development of new business areas such as standard gases and medical gases in H2 2025 [12] - Projected net profits for 2025-2027 are estimated at 1.055 billion, 1.230 billion, and 1.453 billion yuan, respectively, with corresponding PE ratios of 23, 20, and 17 times [12]

Group 1 - The stock price of Maide Medical (688310) closed at 18.74 yuan on August 28, 2025, down 2.55% with a turnover rate of 5.95% and a trading volume of 98,900 hands, resulting in a transaction amount of 191 million yuan [1] - The net inflow of main funds on August 28 was 1.2183 million yuan, accounting for 0.64% of the total transaction amount, while retail investors had a net inflow of 1.2535 million yuan, also accounting for 0.65% [1] - The company reported a main business income of 141 million yuan for the first half of 2025, a year-on-year decrease of 14.75%, and a net profit attributable to shareholders of 6.0451 million yuan, down 38.81% year-on-year [4] Group 2 - The financing data on August 28 showed a financing balance of 87.245 million yuan, with a net repayment of 15.0958 million yuan [2] - The company’s total market value is 3.115 billion yuan, with a net asset of 828 million yuan and a net profit of 6.0451 million yuan, ranking 202nd, 198th, and 185th respectively in the specialized equipment industry [4] - The gross profit margin of Maide Medical is 38.93%, which is higher than the industry average of 27.56% [4]